GSE133087 metformin 3 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE133087_metformin_3_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE133087_metformin_3_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE133087_metformin_3_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE133087_metformin_3_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

HOXD antisense growth-associated long non-coding RNA

Gene

HOXA transcript antisense RNA, myeloid-specific 1

Gene

ATPase H+ transporting V1 subunit G2

Gene

long intergenic non-protein coding RNA 1963

Gene

long intergenic non-protein coding RNA 2381

Gene

FOXD3 antisense RNA 1

Gene

SNX10 antisense RNA 1

Gene

zinc finger protein 286B (pseudogene)

Gene

MIR124-2 host gene

Gene

uncharacterized LOC101928499

  • Gene

    HOXD antisense growth-associated long non-coding RNA


  • Gene

    HOXA transcript antisense RNA, myeloid-specific 1


  • Gene

    ATPase H+ transporting V1 subunit G2


  • Gene

    long intergenic non-protein coding RNA 1963


  • Gene

    long intergenic non-protein coding RNA 2381


  • Gene

    FOXD3 antisense RNA 1


  • Gene

    SNX10 antisense RNA 1


  • Gene

    zinc finger protein 286B (pseudogene)



  • Gene

    uncharacterized LOC101928499

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.